Abstract:Leucine-rich repeat kinase 2 ( LRRK2 ) is the most common gene responsible for familial Parkinson's disease (PD). The gene product of LRRK2 contains multiple protein domains, including armadillo repeat, ankyrin repeat, leucine-rich repeat (LRR), Ras-of-complex (ROC), C-terminal of ROC (COR), kinase, and WD40 domains. In this study, we performed genetic screening of LRRK2 in our PD cohort, detecting sixteen LRRK2 rare variants. Among them, we selected seven variants that are likely to be familial and characterized them in terms of LRRK2 protein function, along with clinical information and one pathological analysis. The seven variants were S1120P and N1221K in the LRR domain; I1339M, S1403R, and V1447M in the ROC domain; and I1658F and D1873H in the COR domain. The kinase activity of the LRRK2 variants N1221K, S1403R, V1447M, and I1658F toward Rab10, a well-known phosphorylation substrate, was higher than that of wild-type LRRK2. LRRK2 D1873H showed enhanced self-association activity, whereas LRRK2 S1403R and D1873H showed reduced microtubule-binding activity. Pathological analysis of a patient with the LRRK2 V1447M variant was also performed, which revealed Lewy pathology in the brainstem. No functional alterations in terms of kinase activity, self-association activity, and microtubule-binding activity were detected in LRRK2 S1120P and I1339M variants. However, the patient with PD carrying LRRK2 S1120P variant also had a heterozygous Glucosylceramidase beta 1 ( GBA1 ) L444P variant. In conclusion, we characterized seven LRRK2 variants potentially associated with PD. Five of the seven variants in different LRRK2 domains exhibited altered properties in kinase activity, self-association, and microtubule-binding activity, suggesting that each domain variant may contribute to disease progression in different ways.

The Small GTPase Activity of the ROC Domain from LRRK2, a Parkinsons Disease Related Protein

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism

Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain.

Kinase Activity of Mutant LRRK2 Mediates Neuronal Toxicity

Leucine-Rich Repeat Kinases

LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain

RedOx regulation of LRRK2 kinase activity by active site cysteines

The Role of the LRRK2 Gene in Parkinsonism

Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2

Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2

Electron Microscopy Structure of Dimeric Lrrk2 Reveals A Structural and Regulatory Role of the Cor Domain

LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis

LRRK2 Mediated Rab8a Phosphorylation Promotes Lipid Storage

Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease

Two Helices Control the Dynamic Crosstalk Between the Catalytic Domains of LRRK2

Expression Profiling and Localization Analysis of Parkinson's Disease Associated Protein LRRK2

Loss-of-function coding variants in the Ras of Complex Proteins/GTPase domain of Leucine Rich Repeat Kinase 2

Membrane remodeling properties of the Parkinson's disease protein LRRK2

Roles of the Drosophila Lrrk2 Homolog in Rab7-Dependent Lysosomal Positioning

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients

Structural Model of the Dimeric Parkinson'S Protein Lrrk2 Reveals A Compact Architecture Involving Distant Interdomain Contacts